# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA662203 | Binding | Compound was evaluated for the inhibition of Chymotrypsinogen | 7 | ALA1129761 | single protein format | Scientific Literature | ||
2. | ALA673225 | Binding | Compound was evaluated for the inhibition of human leukocyte elastase (HLE). | 7 | ALA1129761 | single protein format | Scientific Literature | ||
3. | ALA764238 | Binding | Compound was evaluated for the inhibition of porcine pancreatic elastase (PPE). | 7 | ALA1129761 | single protein format | Scientific Literature | ||
4. | ALA2073149 | Physicochemical | Aqueous solubility of the compound in phosphate buffered saline at pH 7.4 | 48 | ALA2069300 | small-molecule physicochemical format | Scientific Literature | ||
5. | ALA2073150 | ADME | Permeability of the compound at pH 7.4 by PAMPA | 51 | ALA2069300 | assay format | Scientific Literature | ||
6. | ALA2073151 | Binding | Inhibition of LG190178-induced VDR-LBD interaction to Alexa Fluor 647-labeled SRC2-3 after 3 hrs by fluorescence polarization assay | Homo sapiens | 48 | ALA2069300 | single protein format | Scientific Literature | |
7. | ALA2073152 | Binding | Inhibition of VDR-LBD expressed in human HEK293T cells co-expressing GAL4-DBD assessed as inhibition of 1,25-(OH)2D3-induced transcription at 62.5 uM after 24 hrs by FRET based GeneBLAzer assay | Homo sapiens | 17 | ALA2069300 | cell-based format | Scientific Literature | |
8. | ALA2073153 | Binding | Inhibition of VDR-LBD expressed in human HEK293T cells co-expressing GAL4-DBD assessed as inhibition of 1,25-(OH)2D3-induced transcription at 20.8 uM after 24 hrs by FRET based GeneBLAzer assay | Homo sapiens | 17 | ALA2069300 | cell-based format | Scientific Literature | |
9. | ALA2073155 | ADME | Cytotoxicity against human HEK293T cells assessed as cell viability at 20.8 uM by Celltiter-Glo assay | Homo sapiens | 17 | ALA2069300 | cell-based format | Scientific Literature |